Blog – Clinical Trial Results

Dr. Navar and Dr. C. Michael Gibson discuss the CORAL Reef Study: A new novel, oral PCSK9 inhibitor significantly reduces LDL-C.

November 19, 2025

Disclosures: TBD

Dr. Sandesh Dev and Dr. C. Michael Gibson discuss: Geographic Disparities in Transthyretin Amyloid Cardiomyopathy Prevalence in United States Veterans.

November 18, 2025

Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.

Dr. Jim Januzzi and Dr. C. Michael Gibson discuss: Acoramidis Lowers NT-proBNP in a Larger Proportion of ATTRibute-CM Study Participants With Transthyretin Amyloid.

November 17, 2025

Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.

Dr. Shamir Mehta and Dr. C. Michael Gibson discuss the findings of IPD meta-analysis from Complete Revascularization Trialists’ Collaboration: Does complete revasc reduce CV death or new MI compared to culprit-only PCI when considering the totality of RCT data?

November 13, 2025

Disclosures: TBD

Dr. Stephen Nicholls and Dr. C. Michael Gibson Discuss: SURPASS-CVOT — Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure (pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial)

November 10, 2025

Disclosures: TBD

Dr. Ambarish Pandey and Dr. C. Michael Gibson Discuss: FOOD-HF- Examining the Impact of Medically Tailored Meals vs Produce Supplements Delivered Conditionally vs Unconditionally in Heart Failure Readmissions and Emergency Department Visits: A Randomized Clinical Trial

November 10, 2025

Disclosures: TBD

Dr. William F Fearon and Dr. C. Michael Gibson Discuss: CAVIAR- Cardiac Allograft Vasculopathy Inhibition with AliRocumab: The CAVIAR Trial

November 10, 2025

Disclosures: TBD

Dr. Ambarish Pandey and Dr. C. Michael Gibson Discuss: POLY-HF – A Polypill Strategy for Heart Failure with Reduced Ejection Fraction: The POLY-HF Trial

November 10, 2025

Disclosures: TBD

Dr. Colin Berry and Dr. C. Michael Gibson Discuss: CorCMR – Non-Invasive Endotyping in Patients with Angina and No Obstructive Coronary Artery Disease: A Randomized, Controlled Trial

November 10, 2025

Disclosures: TBD

Dr. C. Michael Gibson and Dr. Ginger Jiang Discuss: Zalunfiban at First Medical Contact in Patients with ST-Segment Elevation Myocardial Infarction

November 10, 2025

Disclosures: TBD